Department of Nephrology, University of Naples, Naples, Italy.
Kidney Int. 2011 Jul;80(1):112-8. doi: 10.1038/ki.2011.69. Epub 2011 Mar 30.
We tested for the presence of coronary calcifications in patients with chronic renal disease not on dialysis and studied its progression in 181 consecutive non-dialyzed patients who were followed for a median of 745 days. Coronary calcifications (calcium score) were tallied in Agatston units by computed tomography, and the patients were stratified into two groups by their baseline calcium score (100 U or less and over 100 U). Survival was measured by baseline calcium score and its progression. Cardiac death and myocardial infarction occurred in 29 patients and were significantly more frequent in those patients with calcium scores over 100 U (hazard ratio of 4.11). With a calcium score of 100 U or less, the hazard ratio for cardiac events was 0.41 and 3.26 in patients with absent and accelerated progression, respectively. Thus, in non-dialyzed patients, the extent of coronary calcifications was associated to cardiac events, and progression was an independent predictive factor of cardiac events mainly in less calcified patients. Hence, assessment of coronary calcifications and progression might be useful for earlier management of risk factors and guiding decisions for prevention of cardiac events in this patient population.
我们在未接受透析的慢性肾脏病患者中检测了冠状动脉钙化的存在,并对 181 例连续非透析患者进行了研究,这些患者的中位随访时间为 745 天。冠状动脉钙化(钙评分)通过计算机断层扫描以 Agatston 单位计数,根据基线钙评分(100U 或以下和超过 100U)将患者分层成两组。通过基线钙评分及其进展来衡量生存率。29 例患者发生心脏死亡和心肌梗死,且钙评分超过 100U 的患者发生率明显更高(危险比为 4.11)。钙评分 100U 或以下时,无进展和加速进展患者的心脏事件危险比分别为 0.41 和 3.26。因此,在未接受透析的患者中,冠状动脉钙化的程度与心脏事件相关,且进展是心脏事件的独立预测因素,主要发生在钙化程度较低的患者中。因此,评估冠状动脉钙化和进展可能有助于早期管理该患者人群的危险因素,并指导预防心脏事件的决策。